| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-009289 |
| cik | 1862150 |
| name | CINGULATE INC. |
| sic | 2834 |
| countryba | US |
| stprba | KS |
| cityba | KANSAS CITY |
| zipba | 66205 |
| bas1 | 1901 W. 47TH PLACE |
| bas2 | |
| baph | (913) 942-2300 |
| countryma | US |
| stprma | KS |
| cityma | KANSAS CITY |
| zipma | 66205 |
| mas1 | 1901 W. 47TH PLACE |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 863825535 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 16:41:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009289 | 20241231 | Accounts Payable Current | 1270280.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Accretion Of Discount On Note Payable | 7670.0000 | USD | 1 | 0001641172-25-009289 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | 586511.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20250331 | Assets | 12469588.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Cash And Cash Equivalents At Carrying Value | 12211321.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Cash And Cash Equivalents At Carrying Value | 9518966.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20231130 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Shares Authorized | 125577.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Plan Name= Two Thousand And Twenty One Equity Incentive Plan; | ||
| 0001641172-25-009289 | 20240331 | Depreciation | 163600.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Earnings Per Share Basic | -7.2100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 1483409.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20240331 | Interest Paid Net | 308.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Interest Paid Net | 45.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Operating Income Loss | -2948217.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Operating Income Loss | -3706035.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20230131 | Proceeds From Issuance Of Common Stock | 23500000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= H C Wainwright And Co L L C; Range= Maximum; Type Of Arrangement= A T M Agreement; | ||
| 0001641172-25-009289 | 20250331 | Research And Development Expense | 2222626.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20231231 | Stockholders Equity | -92943443.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20240331 | Stockholders Equity | -95915920.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20241231 | Stockholders Equity | -108489180.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value New Issues | 30.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Value Other | 42.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20241231 | Additional Paid In Capital | 115944345.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 357649.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Amortization Of Financing Costs | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Common Stock Shares Authorized | 240000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Earnings Per Share Basic | -1.0400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Earnings Per Share Diluted | -7.2100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 241524.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Insurance; | ||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -852914.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Operating Lease Liability | 14253.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Long Term Notes Payable | 2436879.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Notes Payable Current | 4124935.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Operating Lease Liability Current | 130662.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20230430 | Proceeds From Issuance Of Common Stock | 12000000.0000 | USD | 0 | us-gaap/2024 | Range= Maximum; Type Of Arrangement= Purchase Agreement; | ||
| 0001641172-25-009289 | 20250331 | Proceeds From Issuance Of Common Stock | 1020368.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= A T M Agreement; | ||
| 0001641172-25-009289 | 20231231 | Stockholders Equity | -6869429.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Stockholders Equity | 340.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Other | 3115284.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Value Other | 1920357.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Assets Current | 10504972.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2692355.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Shares Authorized | 240000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 1141232.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 315685.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Legal And Professional Fees; | ||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 100687.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Occupancy; | ||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 505500.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Legal And Professional Fees; | ||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 571530.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Personnel; | ||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Operating Lease Right Of Use Assets | -73779.0000 | USD | 1 | 0001641172-25-009289 | |||
| 0001641172-25-009289 | 20241231 | Liabilities Current | 4972105.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Liabilities Noncurrent | 923698.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Net Cash Provided By Used In Financing Activities | 1915927.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Net Cash Provided By Used In Operating Activities | -4608282.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Net Income Loss | -3802691.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Nonoperating Income Expense | -24260.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20241231 | Prepaid Expense And Other Assets Current | 423157.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Research And Development Expense | 1806985.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Research And Development Expense | 341199.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Drug Manufacturing And Formulation; | ||
| 0001641172-25-009289 | 20250331 | Research And Development Expense | 1107474.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Clinical Operations; | ||
| 0001641172-25-009289 | 20240331 | Share Based Compensation | 164575.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20231231 | Shares Outstanding | 97293.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20231231 | Stockholders Equity | 10.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | 24024.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | 24024.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3646893.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Additional Paid In Capital | 118222309.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Accounts Payable Current | 855150.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 357649.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Shares Other | 423893.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 149156.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001641172-25-009289 | 20241231 | Assets Current | 12660803.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Common Stock Shares Issued | 3402306.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Shares Issued | 3826199.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Common Stock Shares Outstanding | 3402306.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Shares Outstanding | 3826199.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 61627.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Occupancy; | ||
| 0001641172-25-009289 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Operating Lease Right Of Use Assets | -63078.0000 | USD | 1 | 0001641172-25-009289 | |||
| 0001641172-25-009289 | 20250331 | Liabilities | 6538768.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Liabilities And Stockholders Equity | 14864489.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Income Loss | -2972477.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Research And Development Expense | 561334.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Personnel; | ||
| 0001641172-25-009289 | 20241231 | Retained Earnings Accumulated Deficit | -108489180.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Shares Outstanding | 3826199.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stockholders Equity | 3216119.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Stockholders Equity | 42.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20241231 | Stockholders Equity | 115944345.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value New Issues | 6432862.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Other Receivables | -12375.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Accretion Of Discount On Note Payable | USD | 1 | 0001641172-25-009289 | ||||
| 0001641172-25-009289 | 20241231 | Accrued Liabilities Current | 1039625.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 52415.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 12211321.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Depreciation | 165291.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 413277.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Personnel; | ||
| 0001641172-25-009289 | 20250331 | General And Administrative Expense | 195596.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Insurance; | ||
| 0001641172-25-009289 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -3802691.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Longterm Portion Of Operating Lease Liability | -97518.0000 | USD | 1 | 0001641172-25-009289 | |||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Other Receivables | 15248.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Liabilities | 7408984.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Cash Provided By Used In Investing Activities | -81508.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Cash Provided By Used In Operating Activities | -8746360.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009289 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20250331 | Net Income Loss | -3802691.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20250331 | Other Receivables | 41573.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20240331 | Research And Development Expense | 82644.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Regulatory; | ||
| 0001641172-25-009289 | 20250331 | Research And Development Expense | 380353.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Drug Manufacturing And Formulation; | ||
| 0001641172-25-009289 | 20250331 | Research And Development Expense | 173465.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Regulatory; | ||
| 0001641172-25-009289 | 20250331 | Retained Earnings Accumulated Deficit | -112291871.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Share Based Compensation | 357649.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Shares Outstanding | 417539.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20231231 | Stockholders Equity | 86074004.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20240331 | Proceeds From Issuance Of Common Stock | 9893450.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Proceeds From Issuance Of Common Stock | 3115303.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= A T M Agreement; | ||
| 0001641172-25-009289 | 20240331 | Research And Development Expense | 1077190.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Clinical Operations; | ||
| 0001641172-25-009289 | 20240331 | Research And Development Expense | 305952.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Personnel; | ||
| 0001641172-25-009289 | 20240331 | Share Based Compensation | 164575.0000 | USD | 1 | us-gaap/2024 | Plan Name= Two Thousand And Twenty One Equity Incentive Plan; | ||
| 0001641172-25-009289 | 20241231 | Shares Outstanding | 3402306.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Stockholders Equity | 382.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Shares New Issues | 296000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Shares Other | 23650.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | USD | 1 | 0001641172-25-009289 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | 2734739.0000 | USD | 1 | 0001641172-25-009289 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3646893.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 412126.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 164575.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20250331 | Amortization Of Financing Costs | 76976.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Assets | 14864489.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1113830.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 9518966.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 1061415.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240731 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240531 | Common Stock Shares Authorized | 104167.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Plan Name= Two Thousand And Twenty One Equity Incentive Plan; | ||
| 0001641172-25-009289 | 20241231 | Finance Lease Liability Current | 4430.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | General And Administrative Expense | 70059.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001641172-25-009289 | 20250331 | Long Term Notes Payable | 923698.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Income Loss | -2972477.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20240331 | Payments To Acquire Property Plant And Equipment | 81508.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Prepaid Expense And Other Assets Current | 944433.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Property Plant And Equipment Net | 2104675.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Property Plant And Equipment Net | 1939384.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Share Based Compensation | 357649.0000 | USD | 1 | us-gaap/2024 | Plan Name= Two Thousand And Twenty One Equity Incentive Plan; | ||
| 0001641172-25-009289 | 20241231 | Stockholders Equity | 7455505.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 596.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | USD | 1 | 0001641172-25-009289 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Other | 3115282.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Value Other | 1920315.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 412126.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 164575.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20241231 | Common Stock Value | 340.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Common Stock Value | 382.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Finance Lease Liability Current | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20250331 | Finance Lease Principal Payments | 4430.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Longterm Portion Of Operating Lease Liability | USD | 1 | 0001641172-25-009289 | ||||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1099209.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Liabilities And Stockholders Equity | 12469588.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Nonoperating Income Expense | -96656.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Operating Lease Right Of Use Asset | 99011.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Operating Lease Right Of Use Asset | 25232.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Payments To Acquire Property Plant And Equipment | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009289 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Accrued Liabilities Current | 601840.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | 586511.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009289 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Earnings Per Share Diluted | -1.0400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Finance Lease Principal Payments | 4167.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2972477.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -4995037.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Operating Lease Liability | -97518.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 521276.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Liabilities Current | 5615070.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Liabilities Noncurrent | 2436879.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Cash Provided By Used In Financing Activities | 9889283.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009289 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009289 | 20241231 | Notes Payable Current | 2527108.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Operating Lease Liability Current | 33145.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20241231 | Other Receivables | 26325.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Proceeds From Issuance Of Common Stock | 1920357.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Proceeds From Issuance Of Common Stock | 899989.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= Purchase Agreement; | ||
| 0001641172-25-009289 | 20250430 | Proceeds From Issuance Of Common Stock | 868520.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsequent Event Type= Subsequent Event; Type Of Arrangement= A T M Agreement; | ||
| 0001641172-25-009289 | 20250430 | Proceeds From Issuance Of Common Stock | 749991.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsequent Event Type= Subsequent Event; Type Of Arrangement= Lincoln Park Purchase Agreement; | ||
| 0001641172-25-009289 | 20240331 | Stockholders Equity | 99131997.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Stockholders Equity | 5930820.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20250331 | Stockholders Equity | 118222309.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009289 | 20250331 | Stockholders Equity | -112291871.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | 2734739.0000 | USD | 1 | 0001641172-25-009289 | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | USD | 1 | 0001641172-25-009289 | Equity Components= Common Stock; | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value New Issues | 6432892.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009289 | 20240331 | Stock Issued During Period Value Other | 2.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | 0001641172-25-009289 | 1 | 0 | monetary | D | C | Issuance of pre-funded warrants in connection with the conversion of related party note payable | Stock issued during period value conversion of convertible securities related party note payable. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Receivables | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Receivables | Amount due from parties in nontrade transactions, classified as other. |
| Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital. |
| Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Amortization Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accretion Of Discount On Note Payable | 0001641172-25-009289 | 1 | 0 | monetary | D | D | Accretion of discount on note payable | Accretion of discount on note payable. |
| Increase Decrease In Longterm Portion Of Operating Lease Liability | 0001641172-25-009289 | 1 | 0 | monetary | D | D | Long-term portion of operating lease liability | Increase decrease in long-term portion of operating lease liability. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Increase Decrease In Other Receivables | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Receivables | Amount of increase (decrease) in receivables classified as other. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Finance Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. |
| Increase Decrease In Operating Lease Right Of Use Assets | 0001641172-25-009289 | 1 | 0 | monetary | D | C | IncreaseDecreaseInOperatingLeaseRightOfUseAssets | Operating lease right-of-use assets. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009289 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-009289 | 2 | 4 | BS | 0 | H | Other Receivables | us-gaap/2024 | Other receivables | 0 |
| 0001641172-25-009289 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001641172-25-009289 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-009289 | 2 | 7 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001641172-25-009289 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001641172-25-009289 | 2 | 9 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001641172-25-009289 | 2 | 12 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-009289 | 2 | 13 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001641172-25-009289 | 2 | 14 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Note payable, current | 0 |
| 0001641172-25-009289 | 2 | 15 | BS | 0 | H | Finance Lease Liability Current | us-gaap/2024 | Finance lease liability, current | 0 |
| 0001641172-25-009289 | 2 | 16 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability, current | 0 |
| 0001641172-25-009289 | 2 | 17 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-009289 | 2 | 19 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Note payable | 0 |
| 0001641172-25-009289 | 2 | 20 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total long-term liabilities | 0 |
| 0001641172-25-009289 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001641172-25-009289 | 2 | 23 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock, $0.0001 par value; 240,000,000 shares authorized and 3,826,199 and 3,402,306 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
| 0001641172-25-009289 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
| 0001641172-25-009289 | 2 | 25 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional Paid-in-Capital | 0 |
| 0001641172-25-009289 | 2 | 26 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-009289 | 2 | 27 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001641172-25-009289 | 2 | 28 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001641172-25-009289 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-009289 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-009289 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-009289 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-009289 | 3 | 5 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-009289 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-009289 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-009289 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-009289 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-009289 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-009289 | 4 | 4 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001641172-25-009289 | 4 | 5 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Interest and other income (expense), net | 0 |
| 0001641172-25-009289 | 4 | 6 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001641172-25-009289 | 4 | 7 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax benefit (expense) | 0 |
| 0001641172-25-009289 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss and comprehensive loss | 0 |
| 0001641172-25-009289 | 4 | 9 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share of common stock, basic | 0 |
| 0001641172-25-009289 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share of common stock, diluted | 0 |
| 0001641172-25-009289 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares used in computing net loss per share of common stock, basic | 0 |
| 0001641172-25-009289 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares used in computing net loss per share of common stock, diluted | 0 |
| 0001641172-25-009289 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009289 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009289 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees | 0 |
| 0001641172-25-009289 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares | 0 |
| 0001641172-25-009289 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock in public offering, net of fees | 0 |
| 0001641172-25-009289 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock in public offering, net of fees, shares | 0 |
| 0001641172-25-009289 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities Related Party Note Payable | 0001641172-25-009289 | Issuance of pre-funded warrants in connection with the conversion of related party note payable | 0 |
| 0001641172-25-009289 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt | us-gaap/2024 | Capital contribution in connection with conversion of related party note payable | 0 |
| 0001641172-25-009289 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | Issuance of restricted common stock | 0 |
| 0001641172-25-009289 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Issuance of restricted common stock, shares | 0 |
| 0001641172-25-009289 | 5 | 19 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001641172-25-009289 | 5 | 20 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009289 | 5 | 21 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009289 | 5 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009289 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009289 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001641172-25-009289 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-009289 | 6 | 6 | CF | 0 | H | Accretion Of Discount On Note Payable | 0001641172-25-009289 | Accretion of discount on note payable | 0 |
| 0001641172-25-009289 | 6 | 7 | CF | 0 | H | Amortization Of Financing Costs | us-gaap/2024 | Amortization of debt issue costs | 0 |
| 0001641172-25-009289 | 6 | 9 | CF | 0 | H | Increase Decrease In Other Receivables | us-gaap/2024 | Other receivables | 1 |
| 0001641172-25-009289 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-009289 | 6 | 11 | CF | 0 | H | Increase Decrease In Operating Lease Right Of Use Assets | 0001641172-25-009289 | Operating lease right-of-use assets | 1 |
| 0001641172-25-009289 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Trade accounts payable and accrued expenses | 0 |
| 0001641172-25-009289 | 6 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Current portion of operating lease liability | 0 |
| 0001641172-25-009289 | 6 | 14 | CF | 0 | H | Increase Decrease In Longterm Portion Of Operating Lease Liability | 0001641172-25-009289 | Long-term portion of operating lease liability | 0 |
| 0001641172-25-009289 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001641172-25-009289 | 6 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001641172-25-009289 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001641172-25-009289 | 6 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from the issuance of common stock and pre-funded common stock purchase warrants, net of fees | 0 |
| 0001641172-25-009289 | 6 | 21 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Principal payments on finance lease obligations | 1 |
| 0001641172-25-009289 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001641172-25-009289 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0001641172-25-009289 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of year | 0 |
| 0001641172-25-009289 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001641172-25-009289 | 6 | 28 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |